Buscar
Mostrando ítems 1-10 de 27
Development of a DNA-based vaccine strategy against bovine papillomavirus infection, involving the E5 or L2 gene
(Genetics and Molecular Research, 2017)
Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old.
(American Society for Microbiology, 2014)
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
(Massachusetts Medical Society, 2015)